🫁 #ASCO26 #LungCancer
WU-KONG28: 1L Sunvozertinib in EGFR exon20ins NSCLC
Compared to carbo/pemetrexed, sunvozertinib improved:
🔹mPFS 10.3 vs 7.5 mo (HR 0.65; 95% CI, 0.50 to 0.85)
🔹12mo PFS: 46.1% vs 26.7%
🔹ORR: 58.9% vs 31.1%
🔹mDOR 11.2 vs 7.1 mo
⬆️G3 or higher AEs: 75.5% vs 56.7%
Looking forward to seeing the presentation & discussion today during the metastatic NSCLC Oral Abstracts Session.
Obvious concerns re: comparator arm and how would sunvozertinib perform against current SOC, chemo + amivantamab?
and most importantly, when will this drug be available in the US?
🔗: nejm.org/doi/pdf/10.1056/NEJ…
@ASCO #LCSM @OncodailyLung @OncBrothers @OncoAlert
Excited to be back in Chicago for #ASCO26. So far some interesting lung cancer abstracts being presented. #lungcancer
New publication alert, just in time for #ASCO26
Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, 2026.3.1 | Journal of Clinical Oncology ascopubs.org/doi/10.1200/JCO…
@ASCO @JCO_ASCO
Overall survival of first-line amivantamab plus lazertinib in atypical EGFR-mutated advanced NSCLC. Updated results from the CHRYSALIS-2 study. Median OS ~3.5 years. @JoelNealMD #asco2026 #lungcancer
Dave Bjork retweeted
As I said when this study was first reported, it is a small study with many limitations. At best it is hypothesis generating, nothing more. Please don't accept it at face value.
Crucial reality check from @lungoncdoc: Association ≠ causation‼️ Headlines linking healthy diet/pesticides to young onset lung cancer wildly overstate limited observations without proper controls, confounder adjustment, or any assessment of causality.
instagram.com/reel/DYATLHSvr…
Dave Bjork retweeted
Alicia is honoring her father, grandfather, and uncle by racing in the Chicago Triathlon. Alicia’s father’s passion for medical research inspired her career and to find an organization that supports lung cancer research.
We are honored to have Alicia on the team and look forward to cheering her on this summer.
Learn about Team LUNGevity and how an endurance race can transform lung cancer by visiting teamLUNGevity.org
Dave Bjork retweeted
Crucial reality check from @lungoncdoc: Association ≠ causation‼️ Headlines linking healthy diet/pesticides to young onset lung cancer wildly overstate limited observations without proper controls, confounder adjustment, or any assessment of causality.
instagram.com/reel/DYATLHSvr…
Dave Bjork retweeted
Can’t wait!!
The 4th annual Texas Lung Cancer Conference @TLCconference #TexasLung26 🤠 kicks off in just over 1️⃣ day!
TBH: One of the BEST high-impact conferences you will ever attend, plus it’s held at the @MoodyTheater @acllive! 🎸
Hosted by co-chairs @StephenVLiu & #TinaCascone, and supported by the stellar team at @IDEOlogyHealth.
Texas Lung Hold ‘Em Debate ♥️♦️♣️♠️
🃏 Dealer @JSabari
@BrendonStilesMD vs. @SalmaJabbour1
@lungoncdoc @JuliaRotow @BZhangMD @BalazsHalmosMD @NarjustFlorezMD @Joshua_Reuss @LauraAlderMD @maraantonoff @benlevylungdoc @thenasheffect @tigirlily
Proud to share my latest podcast episode with @LaurenGroner In this clip she talks about the importance of mentorship. @UMiamiHealth @SylvesterCancer See the entire episode youtube.com/watch?v=xwCNlsMb…
#lungcancer #lungcancerscreening #mentorship
I hate to be political on Twitter but really? Is anyone ok with this? I grew up in Minneapolis. This is not what Minnesotans believe. Stop this!
youtu.be/4Do9E-zPCaM?si=zkfj… via @YouTube
Enough! I’ve lived in Boston most of my adult life but Minneapolis is my hometown. I’m heartbroken by this. Sending 2000 ICE agents to provoke & cause chaos is not making America great again. Stop it! Enough! npr.org/2026/01/08/nx-s1-567…
Dave Bjork retweeted
🔎 Early lung cancer screening saves lives, yet far too few eligible patients receive it. This article captures that gap and highlights the leadership of @DouglasEWood1 in pushing for improved access and awareness. seattletimes.com/opinion/ear…
Dave Bjork retweeted
Excited for our #TumorBoardTuesday discussing #ADCs for 2nd line #NSCLC! @SanadAlhushki and I are definitely looking forward to it! Hope you will join the discussion @LungCancerRx
#TumorBoardTuesday
💊Antibody-drug conjugates have been providing hope for several cancer types
📢Join us Tuesday, 12-09-25 at 8PM ET as @ADesaiMD & @SanadAlhushki🗣️the use of Teliso-V (🎯cMET) and T-DXd (🎯HER2) for 2nd Line #NSCLC
RT and bring others into the discussion‼️
Lung cancer screening saves lives! Great work @CedarsSinai #lungcancer @AmLungCSI @ChiFuJeffYang
tinyurl.com/yb35haxr
Dave Bjork retweeted
🚨Efficacy and Safety of Olomorasib in Combination with Pembrolizumab in Treatment of Patients with KRAS G12C-Mutant Advanced NSCLC @JTOonline jto.org/article/S1556-0864%2…
Dave Bjork retweeted
Proud to see @WomenInThoracic in @nytimes. The challenges highlighted are real, yet our meeting was filled with positivity, momentum, and a commitment to a better future for our mentees, patients, and daughters.
Women are wanted and needed in CT surgery!
nytimes.com/2025/11/29/healt…
Dave Bjork retweeted
As 2024 comes to a close, we would like to celebrate the advancements made in small cell lung cancer (#SCLC) that provide hope.
This tremendous progress by clinical trials reflects the innumerable sacrifices made by such dedicated patients & their wonderful families. Thank you!
Dave Bjork retweeted
In this @AATSJournals article with @MDAndersonNews @lungoncdoc, we discuss clinicians’ responsibility to educate: Clear and evidence based messaging shape patient understanding, and social media is an important venue for sharing accurate information. jtcvs.org/article/S0022-5223…
Great news for those impacted by bladder cancer
@WorldBladderCan @BladderCancerUS @DrShariat @DrChoueiri @PGrivasMDPhD @shilpaonc @Uromigos @sophia_kamran @urotoday @Moseyeslee0875 @mdreale @brian_rini @AlbigesL @tompowles1 @pfizer #research #bladdercancer
tinyurl.com/334a3t2w
